Efficacy of Extracorporeal Shockwave Therapy (ESWT) on symptomatic knee osteoarthritis: A randomized double blinded (patient and assessor) controlled trial

Phase 4

• Conditions: Knee osteoarthritis; Extracorporeal shockwave therapy; Visual analogue scale; The Western Ontario and McMaster Univerdities Osteoarthritis Index

• Registration Number: TCTR20170829001
• Lead Sponsor: Ratchadaphiseksomphot Endowment Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-08-29
• Study Completion: 2018-08-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1.OA knee was diagnose by ACR 1986
2.K-L grade 2-3
3.VAS at least 4
4.inforn and consent
5.BMI less than 29.99

Exclusion Criteria

1.knee pain from other condition such as tendinitis
2.systemic arthritis
3.cerebrovascular disease
4.neuromuscular disease
5.history of surgery or traumatic knee
6.paracetamol allergy
7.history of treatment with physical modalities, medication or injection less than 6 months
8.skin conditions such as infection, echymosis
9.impaired cognition
10.history of tretment with ESWT

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS 8 weeks Questionaire

Secondary Outcome Measures

Name	Time	Method
WOMAC 8 weeks Questionaire